Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function

2018 ◽  
Vol 18 (12) ◽  
pp. 1147-1158 ◽  
Author(s):  
Sandra Pisonero-Vaquero ◽  
Diego Luis Medina
Keyword(s):  
2020 ◽  
Vol 144 ◽  
pp. 111575 ◽  
Author(s):  
Jing Lu ◽  
Jianing Lu ◽  
Yan Chen ◽  
Zhe Feng ◽  
Shuang Liu ◽  
...  

Cell Reports ◽  
2021 ◽  
Vol 35 (2) ◽  
pp. 109000
Author(s):  
Frida Sommer ◽  
Vincenzo Torraca ◽  
Yufei Xie ◽  
Aliede E. in ‘t Veld ◽  
Joost Willemse ◽  
...  
Keyword(s):  

2012 ◽  
Vol 198 (1) ◽  
pp. 7-10 ◽  
Author(s):  
Ilya Bezprozvanny

Mutations in presenilins (PS), transmembrane proteins encoding the catalytic subunit of γ-secretase, result in familial Alzheimer’s disease (FAD). Several studies have identified lysosomal defects in cells lacking PS or expressing FAD-associated PS mutations, which have been previously attributed to a function for PS in lysosomal acidification. Now, in this issue, Coen et al. (2012. J. Cell Biol. http://dx.doi.org/10.1083/jcb.201201076) provide a series of results that challenge this idea and propose instead that presenilins play a role in calcium-mediated lysosomal fusion.


Author(s):  
David A. Zeevi ◽  
Ayala Frumkin ◽  
Gideon Bach
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document